TFPI and breast cancer: According to the Kaplan–Meier survival analysis we suggest that higher pre-treatment TF antigen, TF activity, PAI-1 antigen concentration and post-treatment t-PA and TFPI antigen concentration may act as a negative prognostic factor for disease recurrence and may increase the risk of death due to breast cancer.